Discover the future of ophthalmology with Enova® IOL Family
Reviscon® receiving the Play Sure Doping Free certification
Opening of New Office in Dubai
Reviscon Mono 2% receives Health Canada approval
Mastering Presbyopia: Maestro
Partnering with Great Place to Work®
AP News: "Enova Maestro® Launch at Winter ESCRS 2024"
Stay tuned for the reveal of Enovation
Be prepared for Enova Advanced™ Preloaded
Enova Advanced™ EDoF IOL
VSY Biotechnology Announces 2023 Ophthalmology Star Awards Winners
ESCRS President Oliver Findl to Introduce New IOL Technology for Cataract Patients
10% Is Only The Beginning: VSY Biotechnology's Protectalon Dominates German Cataract Surgeries
A Novel Discovery in Eye Care: VSY Biotechnology's 100% Glistening-Free IOL Material
VSY Biotechnology’s Sinusoidal Vision Technology (SVT®) Secures U.S. Patent Grant
Discover The Science Behind Our Commitment
We inspire people to live better


We invest in discovery to create products that make life better for people around the world. It helps us deliver benefits to patients and create value for our shareholders. That is why we come to work each day. We are proud of inspiring to see better and to move better.

We inspire to live better!


Our vision is to achieve innovation-driven growth and to improve the quality of life of our patients while supporting healthcare professionals to achieve their best practices


'Our commitment is to improve the quality of life of our patients.'


'We inspire HCPs with our innovation driven biotechnology solutions.'


AcrivaUD Easy Toric Calculator software for your calculation of the refractive power.

Quality Policy
Our Way of Building Trust

Product quality and safety are always among our top business priorities

News from the frontiers of Biotechnology

Take a tour at featured stories and press releases

Get a Career at VSY Biotechnology GmbH

We offer equal opportunities, diverse and inclusive work environment


Two long-established core areas guide all that we do at VSY Biotechnology


'Intraocular Lenses (IOLs), Ophthalmic Viscosurgical Devices (OVDs) and Injector Systems to treat cataract, presbyopiaand astigmatism.'


'High Molecular Weight Hyaluronic Acid(NaHA) Intra-Articular Injections to treat osteoarthritis.'


Our latest news, updates, announcements and media resources

10% Is Only The Beginning: VSY Biotechnology's Protectalon Dominates German Cataract Surgeries

VSY Biotechnology GmbH is proud to announce a significant achievement in the German market...

VSY Biotechnology’s In-House 100% Glistening-Free IOL Material Redefines The IOL Market

VSY Biotechnology GmbH is pushing the boundaries of ophthalmology with its cutting-edge 100% Glistening-Free IOL Material...

VSY Biotechnology Appoints Hans Jürgen Thier as...

Andreas Kühnel, Managing Director of VSY Biotechnology, headquartered and legally based in Leinfe...